Cargando…
Nivolumab-induced interstitial lung disease in a patient with gastric cancer
We herein report a case of nivolumab-induced interstitial lung disease in a patient with gastric cancer. Nivolumab is a fully human IgG4 monoclonal antibody inhibitor of programmed death-1. A 69-year-old woman with metastatic gastric cancer being treated with nivolumab as fifth-line therapy develope...
Autores principales: | Kimura, Akie, Sakai, Daisuke, Kudo, Toshihiro, Nishida, Naohiro, Katou, Aya, Inagaki, Chiaki, Otsuru, Toru, Miyazaki, Yasuhiro, Tanaka, Koji, Makino, Tomoki, Takahashi, Tsuyoshi, Kurokawa, Yukinori, Yamasaki, Makoto, Mori, Masaki, Doki, Yuichiro, Satoh, Taroh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402314/ https://www.ncbi.nlm.nih.gov/pubmed/30863551 http://dx.doi.org/10.1093/omcr/omz007 |
Ejemplares similares
-
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
por: Urakawa, Shinya, et al.
Publicado: (2017) -
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023) -
Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report
por: Inagaki, Chiaki, et al.
Publicado: (2019) -
Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
por: Hagi, Takaomi, et al.
Publicado: (2020) -
A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide
por: Kato, Ryo, et al.
Publicado: (2016)